Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009; 76 (Suppl 113): S1–130.

• PubMed
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009; 76 (Suppl 113): S1–130.)| false
• Search Google Scholar
• Export Citation

Ketteler M, et al. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD. Kidney Int Suppl 2017; 7[Suppl 1]:1–59.

• PubMed
Ketteler M, KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD. Kidney Int Suppl 2017; 7[Suppl 1]:1–59.)| false
• Search Google Scholar
• Export Citation

Khairallah P, Nickolas TL. Management of osteoporosis in CKD. Clin J Am Soc Nephrol 2018; 13:962–969.

• PubMed
Khairallah P, Nickolas TL. Management of osteoporosis in CKD. Clin J Am Soc Nephrol 2018; 13:962–969.)| false
• Search Google Scholar
• Export Citation

Pimentel A, et al. Fractures in patients with CKD—diagnosis, treatment, and prevention: A review by members of the European Calcified Tissue Society and the European Renal Association—European Dialysis and Transplant Association. Kidney Int 2017; 92:1343–1355.

• PubMed
Pimentel A, Fractures in patients with CKD—diagnosis, treatment, and prevention: A review by members of the European Calcified Tissue Society and the European Renal Association—European Dialysis and Transplant Association. Kidney Int 2017; 92:1343–1355.)| false
• Search Google Scholar
• Export Citation

Isakova T, et al. Longitudinal FGF23 trajectories and mortality in patients with CKD. J Am Soc Nephrol 2018; 29:579–590.

• PubMed
Isakova T, Longitudinal FGF23 trajectories and mortality in patients with CKD. J Am Soc Nephrol 2018; 29:579–590.)| false
• Search Google Scholar
• Export Citation

Ross AC, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab 2011; 96:53–58.

• PubMed
Ross AC, The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab 2011; 96:53–58.)| false
• Search Google Scholar
• Export Citation

Levin A, et al. Randomized controlled trial for the effect of vitamin D supplementation on vascular stiffness in CKD. Clin J Am Soc Nephrol 2017; 12:1447–1460.

• PubMed
Levin A, Randomized controlled trial for the effect of vitamin D supplementation on vascular stiffness in CKD. Clin J Am Soc Nephrol 2017; 12:1447–1460.)| false
• Search Google Scholar
• Export Citation

Kumar V, et al. A randomized trial of vitamin D supplementation on vascular function in CKD. J Am Soc Nephrol 2017; 28:3100–3108.

• PubMed
Kumar V, A randomized trial of vitamin D supplementation on vascular function in CKD. J Am Soc Nephrol 2017; 28:3100–3108.)| false
• Search Google Scholar
• Export Citation

Courbebaisse M, et al. Non-skeletal and skeletal effects of high doses versus minimum recommended intake of vitamin D3 in renal transplant recipients in a prospective, multicenter, double-blind, randomized study. Late Breaking Clinical Trial Abstract, ERA-EDTA Congress 2019, Budapest.

• PubMed
Courbebaisse M, Non-skeletal and skeletal effects of high doses versus minimum recommended intake of vitamin D3 in renal transplant recipients in a prospective, multicenter, double-blind, randomized study. Late Breaking Clinical Trial Abstract, ERA-EDTA Congress 2019, Budapest.)| false
• Search Google Scholar
• Export Citation

Sprague SM, et al. Use of extended-release calcifediol to treat secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. Am J Nephrol 2016; 44:316–325.

• PubMed
Sprague SM, Use of extended-release calcifediol to treat secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. Am J Nephrol 2016; 44:316–325.)| false
• Search Google Scholar
• Export Citation

Strugnell SA, et al. Rationale for raising current clinical practice guideline target for serum 25-hydroxyvitamin D in chronic kidney disease. Am J Nephrol 2019; 49:284–293.

• PubMed
Strugnell SA, Rationale for raising current clinical practice guideline target for serum 25-hydroxyvitamin D in chronic kidney disease. Am J Nephrol 2019; 49:284–293.)| false
• Search Google Scholar
• Export Citation

Cozzolino M, Ketteler M. Evaluating extended-release calcifediol as a treatment option for chronic kidney disease-mineral and bone disorder (CKD-MBD). Expert Opin Pharmacother. 2019; 20: 2081-2093.

• PubMed
Cozzolino M, Ketteler M. Evaluating extended-release calcifediol as a treatment option for chronic kidney disease-mineral and bone disorder (CKD-MBD). Expert Opin Pharmacother. 2019; 20: 2081-2093.)| false
• Search Google Scholar
• Export Citation

Scragg R, et al. Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study: A randomized clinical trial. JAMA Cardiol 2017; 2:608–616.

• PubMed
Scragg R, Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study: A randomized clinical trial. JAMA Cardiol 2017; 2:608–616.)| false
• Search Google Scholar
• Export Citation

Scragg R, et al. Monthly high-dose vitamin D supplementation and cancer risk: A post hoc analysis of the vitamin D assessment randomized clinical trial. JAMA Oncol 2018; 4:e182178.

• PubMed
Scragg R, Monthly high-dose vitamin D supplementation and cancer risk: A post hoc analysis of the vitamin D assessment randomized clinical trial. JAMA Oncol 2018; 4:e182178.)| false
• Search Google Scholar
• Export Citation

Manson JE, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 2019; 380:33–44.

• PubMed
Manson JE, Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 2019; 380:33–44.)| false
• Search Google Scholar
• Export Citation

de Boer IH, Zelnick LR, Ruzinski J, et al. Effect of vitamin D and omega-3 fatty acid supplementation on kidney function in patients with type 2 diabetes: A randomized clinical Trial. JAMA. 2019; doi: 10.1001/jama.2019.17380.

• PubMed
de Boer IH, Zelnick LR, Ruzinski J, Effect of vitamin D and omega-3 fatty acid supplementation on kidney function in patients with type 2 diabetes: A randomized clinical Trial. JAMA. 2019; doi: 10.1001/jama.2019.17380.)| false
• Search Google Scholar
• Export Citation